BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20921545)

  • 1. Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force.
    Chou R; Dana T
    Ann Intern Med; 2010 Oct; 153(7):461-8. PubMed ID: 20921545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening adults aged 50 years or older for hearing loss: a review of the evidence for the U.S. preventive services task force.
    Chou R; Dana T; Bougatsos C; Fleming C; Beil T
    Ann Intern Med; 2011 Mar; 154(5):347-55. PubMed ID: 21357912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2011 Aug; 155(4):246-51. PubMed ID: 21844550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for testicular cancer: an evidence review for the U.S. Preventive Services Task Force.
    Lin K; Sharangpani R
    Ann Intern Med; 2010 Sep; 153(6):396-9. PubMed ID: 20855803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Arora B; Dana T; Fu R; Walker M; Humphrey L
    Ann Intern Med; 2011 Sep; 155(6):375-85. PubMed ID: 21930855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force.
    Rugge JB; Bougatsos C; Chou R
    Ann Intern Med; 2015 Jan; 162(1):35-45. PubMed ID: 25347444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.
    Lotan Y; Elias K; Svatek RS; Bagrodia A; Nuss G; Moran B; Sagalowsky AI
    J Urol; 2009 Jul; 182(1):52-7; discussion 58. PubMed ID: 19450825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening older adults for impaired visual acuity: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Dana T; Bougatsos C
    Ann Intern Med; 2009 Jul; 151(1):44-58, W11-20. PubMed ID: 19581646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.
    Parekattil SJ; Fisher HA; Kogan BA
    J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
    Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
    BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.
    Kamat AM; Hegarty PK; Gee JR; Clark PE; Svatek RS; Hegarty N; Shariat SF; Xylinas E; Schmitz-Dräger BJ; Lotan Y; Jenkins LC; Droller M; van Rhijn BW; Karakiewicz PI;
    Eur Urol; 2013 Jan; 63(1):4-15. PubMed ID: 23083902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force.
    Selph S; Dana T; Blazina I; Bougatsos C; Patel H; Chou R
    Ann Intern Med; 2015 Jun; 162(11):765-76. PubMed ID: 25867111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.
    Chou R; Selph S; Dana T; Bougatsos C; Zakher B; Blazina I; Korthuis PT
    Ann Intern Med; 2012 Nov; 157(10):706-18. PubMed ID: 23165662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force.
    Nelson HD; Haney EM; Dana T; Bougatsos C; Chou R
    Ann Intern Med; 2010 Jul; 153(2):99-111. PubMed ID: 20621892
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.